Translational Diabetes Prevention in GDM

Conditions:		Gestational Diabetes
Purpose:		The purpose of this research study is to implement and evaluate a lifestyle program designed to help women who have high glucose levels during pregnancy make healthful diet and physical activity changes to lose weight. Eligible women will be randomly assigned to life-style intervention or usual medical care.
Study Summary:
Criteria:		Inclusion Criteria: - Women receiving prenatal care at Kaiser Permanente Santa Clara, Santa Teresa, Hayward, and Oakland - Pregnancy complicated by high glucose levels starting November 2011 Exclusion Criteria: - Recognized DM prior to pregnancy - Uncontrolled hypertension during pregnancy - Severe active thyroid disease during pregnancy - Severe diseases of the cardio-pulmonary system - Diagnosis of a severe psychiatric disorder - Diagnosis of cancer - Conditions that lead to diet changes - Addiction to alcohol or illegal drugs - Current corticosteroid medicine use
NCT ID:		NCT01489163
Primary Contact:		Principal Investigator Assiamira Ferrara, MD, PhD Kaiser Permanente Division of Research Assiamira Ferrara, MD, PhD Phone: 510-891-3588 Email: assiamira.ferrara@kp.org
Backup Contact:		Email: samantha.ehrlich@kp.org Samantha F Ehrlich, MPH, PhD Phone: 510-891-3505
Location Contact:		Oakland, California 94612 United States Samatha F Ehrlich, MPH, PhD Phone: 510-891-3503 Email: samanatha.ehrlich@kp.org Site Status: Recruiting

Data Source:		ClinicalTrials.gov
Date Processed:		May 22, 2013
Modifications to this listing:		Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"

First Name:

Last Name:

Email Address:

Confirm Email:

Daytime Phone (eg. 555-555-5555):

City:

State:

Zip Code:

Best Time to Call:

Morning	Afternoon	Evening
Please contact me by email instead of calling.

Questions/Comments:

I have read and agree with the Privacy Policy

I have reviewed the eligibility criteria and believe I am eligible for this clinical trial

I would like to be notified about new clinical trials.